Questcor Announces Initial Commercialization Plans for Acthar Rheumatology Indications – Yahoo Finance

Acthar was administered to five patients who had previously failed multiple steroid and immunosuppressant treatment regimens.  The patients received injections of Acthar over the course of 12 weeks or more.  Improvement in PM and DM symptoms …